BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng M, Li YM, Liu ZY, Zhang X, Zhou Y, Jiang JL, Zhu P, Yang XM, Tang J, Chen ZN. Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer. Front Immunol 2021;12:731329. [PMID: 35069521 DOI: 10.3389/fimmu.2021.731329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hou W, Yi C, Zhu H. Predictive biomarkers of colon cancer immunotherapy: Present and future. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1032314] [Reference Citation Analysis]
2 Heo CK, Lim WH, Park I, Choi YS, Lim KJ, Cho EW. Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA. Int J Oncol 2022;61:158. [PMID: 36321789 DOI: 10.3892/ijo.2022.5448] [Reference Citation Analysis]
3 Picca A, Finocchiaro G. Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results. Curr Opin Oncol 2022. [PMID: 36000367 DOI: 10.1097/CCO.0000000000000895] [Reference Citation Analysis]
4 Guan L, Tang Y, Li G, Qin Z, Li S. Comprehensive Analysis of Role of Cyclin-Dependent Kinases Family Members in Colorectal Cancer. Front Oncol 2022;12:921710. [DOI: 10.3389/fonc.2022.921710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]